Brompton Global Healthcare Income & Growth ETF

Actively managed portfolio of large-cap global Healthcare companies.

MARKET PRICE
(Jul 17, 2026)
$7.38
YIELD
(Jul 17, 2026)
8.94%
NAV
(Jul 16, 2026)
$7.43
TOTAL ASSETS
(Jul 17, 2026)
$66M

Healthcare Sector Covered Call ETF with Monthly Income

 

Brompton Global Healthcare Income & Growth ETF (HIG) is designed to provide stable monthly distributions and the opportunity for capital appreciation by investing in an actively managed portfolio of large-cap global Healthcare companies. This Healthcare ETF uses an active covered call writing program to generate additional income and reduce overall portfolio volatility.  

 

Investment Highlights:

  • Access to leading global Healthcare companies
  • Stable monthly income plus growth potential 
  • Covered call writing to enhance income and lower portfolio volatility 
  • Long term demographic trends are supportive of Healthcare equities   

Why Invest in Healthcare?

  • Global healthcare companies have historically outperformed the broader equity market with lower volatility1
  • Aging population, rising incomes, and innovation are driving long-term growth opportunities for the healthcare sector1
  • Under-represented sector in the Canadian equity market; global Healthcare equities provide diversification benefits1

Fund Facts

  • Ticker (CAD Hedged)
  • CUSIP (CAD Hedged)
    11222T105
  • Outstanding (CAD Hedged)
    (Jul 17, 2026)8,914,891
  • Ticker (USD Unit)
  • CUSIP (USD Unit)
    11222T204
  • Outstanding (USD Unit)
    (Jul 17, 2026)97,500
  • Inception Date (CAD Hedged)
    September 24, 2015
  • Inception Date (USD)
    August 8, 2019
  • Management Fee
    0.75%
  • Management Style
    Active
  • Management Fee
    0.75%
  • Management Style
    Active
  • Manager/Portfolio Manager
    Brompton Funds Limited
  • Currency
    CAD-Hedged
  • Eligibility
    All registered (RRSP, RRIF, RESP, TFSA, FHSA) and Non-Registered Investment Accounts
  • Sub Advisor
    Brompton Funds Limited
  • Risk Rating
    Medium

Managed by Brompton Funds Limited

Founded in 2000, Brompton is an experienced investment fund manager with income and growth focused investment solutions including exchange-traded funds (ETFs), split share funds, and other TSX traded investment funds. Our funds are designed to address investors’ cash flow requirements and to provide them with value-added diversification strategies. Since inception, Brompton has paid out over $4.0 billion in distributions. For the level of service provided, our funds are known for their low management fees and costs.

Michael Clare

BComm (Hons), CPA, CA, CFA
Senior Vice President, Senior Portfolio Manager

Michael Clare has over 20 years of experience in financial services and is a Senior Vice President and Senior Portfolio Manager with Brompton Group. Mr. Clare is a member of Brompton’s portfolio management team and is a co-manager of investment funds at Brompton with combined assets of over $3 billion. He specializes in portfolio construction, security analysis, and covered call strategies with a focus on technology, health care, financials, energy, global equities, and low volatility strategies.

Laura Lau

BASc (Hons), CFA, DMS
Chief Investment Officer

Laura Lau has 25 years investment experience and is the Chief Investment Officer with Brompton Funds. Ms. Lau leads Brompton’s portfolio management team that oversees assets of over $3 billion primarily in global and Canadian covered call mandates designed to generate income and lower volatility of returns.

Summary of Investment Portfolio as at June 30, 2026

Summary of Investment Portfolio as at June 30, 2026

Total Net Asset Value $66,465,000
82.0,7.0,5.8,3.8,3.4,3.2,2.4,
39.3,13.8,11.4,10.3,7.5,5.1,4.5,4.4,4.1,3.8,3.4,

Top 25 Holdings

% of Portfolio
% of Net Asset Value
Johnson & Johnson
6.1%
Novartis AG ADR
5.8%
Eli Lilly and Co.
5.6%
Cardinal Health, Inc.
5.6%
UnitedHealth Group Inc.
5.1%
Gilead Sciences, Inc.
4.8%
Vertex Pharmaceuticals Inc.
4.7%
Bristol-Myers Squibb Co.
4.7%
Agilent Technologies Inc.
4.5%
Merck & Co Inc.
4.5%
Welltower Inc.
4.4%
Amgen Inc.
4.2%
HCA Healthcare Inc.
4.1%
McKesson Corp.
4.0%
GSK PLC ADR
4.0%
CVS Health Corp.
3.9%
Cigna Group
3.8%
Cash
3.4%
UCB S.A.
3.2%
AstraZeneca PLC ADR
3.1%
Danaher Corp.
3.1%
Quest Diagnostics Inc.
2.6%
Edwards Lifesciences Corp.
2.5%
TEVA Pharmaceutical Industries Ltd. ADR
2.4%
Intuitive Surgical Inc.
1.9%
Total102%
Performance NAV History

Growth of $10,000(1)

Performance

Annual Compound Returns(2)(3)

YTD 1-Year 3-Year 5-Year 10-Year Since Inception(4) Since Inception(5) Since Inception(2)
Brompton Global Healthcare Income & Growth ETF - CAD Hedged (2.7%) 7.1% 3.3% 1.2% 5.2% 5.0% N.A.
Brompton Global Healthcare Income & Growth ETF - USD (2.0%) 8.9% 4.8% 2.1% N.A. N.A. 5.0%

Year-by-Year Returns(2)

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Brompton Global Healthcare Income & Growth ETF - CAD Hedged 13.5% (0.1%) (1.5%) (14.3%) 24.1% 6.3% 22.0% 5.0% 11.2% (6.3%)
Brompton Global Healthcare Income & Growth ETF - USD 16.1% 0.6% (0.9%) (14.4%) 24.0% 8.4% 7.2%(6) n.a. n.a. n.a.

Distributions Table

Select a year
Record Date Payment Date Capital Gains Eligible Dividend Foreign Non- Business Income Foreign Non- Business Income Tax Paid Other Income Return of Capital Total Distribution
Jun 30, 2026 Jul 09, 2026 * * * * * * 0.05500
May 29, 2026 Jun 08, 2026 * * * * * * 0.05500
Apr 30, 2026 May 08, 2026 * * * * * * 0.05500
Mar 31, 2026 Apr 15, 2026 * * * * * * 0.05500
Feb 27, 2026 Mar 13, 2026 * * * * * * 0.05500
Jan 30, 2026 Feb 13, 2026 * * * * * * 0.05500
Dec 31, 2025 Jan 15, 2026 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Nov 28, 2025 Dec 12, 2025 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Oct 31, 2025 Nov 14, 2025 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Sep 30, 2025 Oct 15, 2025 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Aug 29, 2025 Sep 15, 2025 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Jul 31, 2025 Aug 15, 2025 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Total 0.00000 0.00000 0.00000 0.00000 0.00000 0.33000 0.66000

Distributions

The actual breakdown of distributions for tax purposes will be provided to unitholders annually in March. This information will also be posted on the website as soon as it is available.

This information is of a general nature only and does not constitute legal or tax advice to any particular investor. Accordingly, prospective investors are advised to consult their own tax advisors with respect to their individual circumstances.

Tax Allocation

The following information is applicable to holders who, for the purposes of the Income Tax Act (Canada), are resident in Canada and hold trust units as capital property. If this is not the case, a tax advisor should be consulted.

Holders of trust units outside of a RRSP, DPSP, RRIF, RESP or TFSA should expect to receive a T3 slip from their investment dealer. T3 supplementary slips will indicate Investment Income in Box 26, Foreign Non-Business Income in Box 25, Capital Gains in Box 21 and Dividend Income in Box 23 and Box 49. Dividend income is subject to the standard gross up and federal dividend tax credit rules.

The return of capital component is a non-taxable amount that serves to reduce the adjusted cost base of the Fund units and is reported in Box 42.

Disclaimer

Fund Documents

  • Fund Profile
  • Profil du Fonds
  • Portfolio Summary
  • Commentary
  • Commentaire
  • Why Invest
  • Covered Call Primer
  • KYP Resources


News Releases

News Releases From to Search

Distributions Table

Select a year
Record Date Payment Date Capital Gains Eligible Dividend Foreign Non- Business Income Foreign Non- Business Income Tax Paid Other Income Return of Capital Total Distribution
Jun 30, 2026 Jul 09, 2026 * * * * * * 0.05500
May 29, 2026 Jun 08, 2026 * * * * * * 0.05500
Apr 30, 2026 May 08, 2026 * * * * * * 0.05500
Mar 31, 2026 Apr 15, 2026 * * * * * * 0.05500
Feb 27, 2026 Mar 13, 2026 * * * * * * 0.05500
Jan 30, 2026 Feb 13, 2026 * * * * * * 0.05500
Dec 31, 2025 Jan 15, 2026 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Nov 28, 2025 Dec 12, 2025 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Oct 31, 2025 Nov 14, 2025 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Sep 30, 2025 Oct 15, 2025 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Aug 29, 2025 Sep 15, 2025 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Jul 31, 2025 Aug 15, 2025 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Total 0.00000 0.00000 0.00000 0.00000 0.00000 0.33000 0.66000

Distributions

The actual breakdown of distributions for tax purposes will be provided to unitholders annually in March. This information will also be posted on the website as soon as it is available.

This information is of a general nature only and does not constitute legal or tax advice to any particular investor. Accordingly, prospective investors are advised to consult their own tax advisors with respect to their individual circumstances.

Tax Allocation

The following information is applicable to holders who, for the purposes of the Income Tax Act (Canada), are resident in Canada and hold trust units as capital property. If this is not the case, a tax advisor should be consulted.

Holders of trust units outside of a RRSP, DPSP, RRIF, RESP or TFSA should expect to receive a T3 slip from their investment dealer. T3 supplementary slips will indicate Investment Income in Box 26, Foreign Non-Business Income in Box 25, Capital Gains in Box 21 and Dividend Income in Box 23 and Box 49. Dividend income is subject to the standard gross up and federal dividend tax credit rules.

The return of capital component is a non-taxable amount that serves to reduce the adjusted cost base of the Fund units and is reported in Box 42.



News Releases

News Releases From to Search

Market Data provided by TMX, and powered by QuoteMedia

This webpage is for information purposes only and does not constitute an offer to sell or a solicitation to buy the securities referred to herein. The opinions contained in this report are solely those of Brompton Funds Limited (“BFL”) and are subject to change without notice. BFL makes every effort to ensure that the information has been derived from sources believed to be reliable and accurate. However, BFL assumes no responsibility for any losses or damages, whether direct or indirect which arise from the use of this information. BFL is under no obligation to update the information contained herein. The information should not be regarded as a substitute for the exercise of your own judgment. Please read the prospectus before investing.

Commissions, trailing commissions, management fees and expenses all may be associated with exchange-traded fund investments. Please read the prospectus before investing. The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Exchange-traded funds are not guaranteed, their values change frequently and past performance may not be repeated.

Information contained on this webpage was published at a specific point in time. Upon publication, it is believed to be accurate and reliable, however, we cannot guarantee that it is complete or current at all times. Certain statements contained on this webpage constitute forward-looking information within the meaning of Canadian securities laws. Forward-looking information may relate to matters disclosed on this webpage and to other matters identified in public filings relating to the ETF, to the future outlook of the ETF and anticipated events or results and may include statements regarding the future financial performance of the ETF. In some cases, forward-looking information can be identified by terms such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue” or other similar expressions concerning matters that are not historical facts. Actual results may vary from such forward-looking information. Investors should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and we assume no obligation to update or revise them to reflect new events or circumstances.